Spruce Biosciences Inc (NASDAQ: SPRB) is -85.31% lower on its value in year-to-date trading and has touched a low of $0.37 and a high of $5.95 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SPRB stock was last observed hovering at around $0.40 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.43, the stock is -5.74% and -14.12% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.74 million and changing 8.80% at the moment leaves the stock -28.15% off its SMA200. SPRB registered -82.65% loss for a year compared to 6-month loss of -19.15%. The firm has a 50-day simple moving average (SMA 50) of $0.5018 and a 200-day simple moving average (SMA200) of $0.621565.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -15.99% gain in the last 1 month and extending the period to 3 months gives it a -1.74%, and is 12.61% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.75% over the week and 8.20% over the month.
Spruce Biosciences Inc (SPRB) has around 29 employees, a market worth around $17.78M and $7.10M in sales. Profit margin for the company is -555.23%. Distance from 52-week low is 17.89% and -92.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-74.43%).
with sales reaching $885k over the same period.The EPS is expected to grow by 24.68% this year, but quarterly earnings will post -49.52% year-over-year. Quarterly sales are estimated to shrink -69.35% in year-over-year returns.
37.0 institutions hold shares in Spruce Biosciences Inc (SPRB), with institutional investors hold 52.17% of the company’s shares. The shares outstanding are 41.30M, and float is at 27.36M with Short Float at 0.80%. Institutions hold 46.69% of the Float.
The top institutional shareholder in the company is RIVERVEST VENTURE MANAGEMENT LLC with over 2.94 million shares valued at $1.52 million. The investor’s holdings represent 7.1449 of the SPRB Shares outstanding. As of 2024-06-30, the second largest holder is CARLYLE GROUP INC. with 2.9 million shares valued at $1.52 million to account for 7.0481 of the shares outstanding. The other top investors are ROCK SPRINGS CAPITAL MANAGEMENT LP which holds 2.61 million shares representing 6.3488 and valued at over $1.35 million, while ROSALIND ADVISORS, INC. holds 3.6705 of the shares totaling 1.51 million with a market value of $0.78 million.
Spruce Biosciences Inc (SPRB) Insider Activity
The most recent transaction is an insider sale by Novo Holdings A/S, the company’s 10% Owner. SEC filings show that Novo Holdings A/S sold 465,021 shares of the company’s common stock on Mar 21 ’24 at a price of $0.75 per share for a total of $0.35 million. Following the sale, the insider now owns 2.55 million shares.
Spruce Biosciences Inc disclosed in a document filed with the SEC on Mar 18 ’24 that Novo Holdings A/S (10% Owner) sold a total of 842,020 shares of the company’s common stock. The trade occurred on Mar 18 ’24 and was made at $0.77 per share for $0.65 million. Following the transaction, the insider now directly holds 3.97 million shares of the SPRB stock.
Still, SEC filings show that on Mar 19 ’24, Novo Holdings A/S (10% Owner) disposed off 593,000 shares at an average price of $0.76 for $0.45 million. The insider now directly holds 3,375,000 shares of Spruce Biosciences Inc (SPRB).
